Page last updated: 2024-10-18

dihydroxyphenylalanine and Cancer of Esophagus

dihydroxyphenylalanine has been researched along with Cancer of Esophagus in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research Excerpts

ExcerptRelevanceReference
"Patients with esophageal and gastric cancer show a decreased diurnal excretion of DOPA matched by a considerable drop in the urine levels of catecholamines and their main metabolites as compared with healthy subjects."1.27[Impaired function of the sympatho-adrenal system in patients with esophageal and stomach cancer]. ( Balitskiĭ, KP; Paliukh, VB; Shmal'ko, IuP; Tarutinov, VI; Vinnitskiĭ, VB, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tarutinov, VI1
Paliukh, VB1
Vinnitskiĭ, VB1
Shmal'ko, IuP1
Balitskiĭ, KP1

Other Studies

1 other study available for dihydroxyphenylalanine and Cancer of Esophagus

ArticleYear
[Impaired function of the sympatho-adrenal system in patients with esophageal and stomach cancer].
    Voprosy onkologii, 1984, Volume: 30, Issue:8

    Topics: Adrenal Glands; Adult; Catecholamines; Cholinesterases; Dihydroxyphenylalanine; Esophageal Neoplasms

1984